Harokopio University of Athens
Kallithea, Attica, 17671, Greece
NCT Number: NCT02543671
The primary aim of the current study was to investigate whether the consumption of vitamin D3 enriched, reduced-fat yellow cheese can counterbalance the expected decrease in serum 25-hydroxyvitamin D concentration during winter in postmenopausal women in Greece, and in what degree it can contribute as a potential food-based strategy for the prevention of vitamin D deficiency. A secondary aim was also to investigate any potential effect of the intervention in several quality of life (QoL) indices in the population of postmenopausal women under study.
Looking for future studies?
Notify Me55 year–75 year
Female
Interventional
Not applicable
Kallithea, Attica, 17671, Greece
Vitamin D status in postmenopausal women is of interest because of the association of low vitamin D status with increased risk of osteoporosis and related fractures. In addition, since there is increasing evidence that the dietary supply is often insufficient to offset the seasonal deficit in sunlight during winter months, fortified food and supplements are becoming important sources of dietary vitamin D intake to achieve optimal vitamin D status, especially in this high risk population. Although most studies have examined the effectiveness of vitamin D enriched milk and yogurt, there have been limited studies also exploring the effectiveness of vitamin D enriched cheese in enhancing vitamin D status and preventing vitamin D deficiency. However, fortification of cheese with vitamin D has certain technological considerations, particularly for reduced-fat varieties considering that vitamin D is a fat soluble nutrient.
The primary aim of the current study was to investigate whether the consumption of vitamin D3 enriched, reduced-fat yellow cheese can counterbalance the expected decrease in serum 25-hydroxyvitamin D concentration during winter in postmenopausal women in Greece, and in what degree it can contribute as a potential food-based strategy for the prevention of vitamin D deficiency. A secondary aim was also to investigate any potential effect of the intervention in several quality of life (QoL) indices in the population of postmenopausal women under study. .
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
60 grams of vitamin D3 enriched, reduced-fat yellow cheese provide 5.7 micrograms of vitamin D per day for 8 weeks
60 grams of plain (non-fortified), reduced-fat yellow cheese provide 0 micrograms of vitamin D per day for 8 weeks
Time frame: 8 weeks
Time frame: 8 weeks
score range from 0 [worst disability related to physical functioning] to 100 [no disability related to physical functioning]
Time frame: 8 weeks
score range from 0 [worst disability related to limitations due to physical health] to 100 [no disability related to limitations due to physical health]
Time frame: 8 weeks
score range from 0 [worst disability related to limitations due to emotional problems] to 100 [no disability related to limitations due to emotional problems]
Time frame: 8 weeks
score range from 0 [worst disability related to vitality to 100 [no disability related to vitality]
Time frame: 8 weeks
score range from 0 [worst disability related to emotional well-being to 100 [no disability related to emotional well-being]
Time frame: 8 weeks
score range from 0 [worst disability related to social functioning to 100 [no disability related to social functioning]
Time frame: 8 weeks
score range from 0 [worst disability related to bodily pain] to 100 [no disability related to bodily pain]
Time frame: 8 weeks
score range from 0 [worst general health] to 100 [best general health]
Harokopio University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06551688
Avitaminosis, Breast Diseases
El Fayoum Qesm, Faiyum Governorate, Egypt
View Trial DetailsNCT04556136
Avitaminosis, Deficiency Diseases
Tacoma, Washington, United States
View Trial DetailsNCT06115356
Avitaminosis, Body Weight
Trieste, Italy
View Trial DetailsNCT05957692
Avitaminosis, Deficiency Diseases
Verona, Italy
View Trial Details